The Best Dogs Of The Dow Jones | Cheapest Stocks On The Index
Many people ask themselves how to make money with stocks and generate a second income that is high enough to retiree a few years earlier in order to enjoy the lifetime a bit more. Most investors try to search a safe investment strategy that works really well. A Strategy, simple enough to understand and easy to implement. Some investment strategies fail, others work well but every tactic is not forever. It comes the time when the market forces change.
100 Attractive Stocks, Bought By Famous Investment Gurus Between May - October 2012
Stocks With Recent Engagements By Investment Professionals Researched By Dividend Yield – Stock, Capital, Investment. Investment gurus are asset or fund managers with big amounts of cash under management. They became popular by big returns and spectacular investment strategies. I talk about investors like George Soros and Warren Buffett. They all have one thing in common: The average return beats the market and if they invest, the market follows.
I made a screen of the biggest stock buys from 49 super investors over the recent six month and ranked them in my 100 best guru buy list. They all bought 502 stocks within the past half year.
The top stocks are Oracle (ORCL) and Google (GOOG). Google was bought by fourteen investment professionals and Oracle by eleven. ORCL stocks are one of the hot plays for investors because they are in average long in the stock with 0.52 percent of their full portfolio.
(JNJ, CRWE, ABG, EXPR) Stocks in Focus by CRWEFinance.com
(GFN, SJM, NPO, JNJ) Stocks in Focus by DrStockPick.com
These Stocks May Be Better Than Their Dow Equivalents
(CSC, CLNO, JNJ, CUZ, GCAP) Stock in Review by DrStockPick.com
(PROJ, MD, JNJ, CLNO, GD) Stocks to Watch by StockHotTips.com
Deltek, Inc. (Nasdaq:PROJ) is the leading global provider of enterprise software and information solutions for professional services firms and government contractors. For decades, Deltek has delivered actionable insight that empowers our customers to unlock their business potential.
(JNJ, CLNO, DO, DLR) Stock Updates by DoubleInStocks.com
Johnson & Johnson (NYSE:JNJ) announced that its Board of Directors has declared a cash dividend for the fourth quarter of 2011 of $0.57 per share on the company's common stock. The dividend is payable on Dec. 13, 2011, to shareholders of record at the close of business on Nov. 29, 2011. The ex-dividend date is Nov. 25, 2011.
(JNJ, UPS, RNR, GBLHF.PK) Stock Report from DrStockPick.com
Johnson & Johnson (NYSE:JNJ) announced important progress made in the inaugural year of the Company's comprehensive effort designed to improve the health of as many as 120 million women and children each year in developing countries by 2015.
Johnson & Johnson engages in the research and development, manufacture, and sale of various products in the health care field worldwide.